scispace - formally typeset
Search or ask a question

What are the voluntary risk factors for lung cancer? 

Answers from top 10 papers

More filters
Papers (10)Insight
The greatest risk by far for developing lung cancer is cigarette smoking, but age, radon exposure, environmental pollution, occupational exposures, gender, race, and pre-existing lung disease also are important contributors.
In our study, smoking was the principal risk factor for lung cancer.
The risk of lung cancer varies widely among smokers.
Of the major risk factors for lung cancer, direct smoking has the greatest influence.
Moreover, the contribution of other environmental, occupational and socioeconomic factors may be more apparent as etiological factors for lung cancer in a population with relatively high lung cancer incidence but low AR from active smoking.
The data suggest that tobacco smoking is the most important risk factor for the development of lung cancer in this setting.
These results suggest that previous lung diseases influence lung cancer risk independently of tobacco use and that these diseases are important for assessing individual risk.
It is highly possible that environmental factors are also responsible for lung cancer cases.
Determinants of cancer perceived risk and worries vary in individuals depending on the level of lung cancer risk.
Our results support the hypothesis that some nonmalignant respiratory diseases may be independent risk factors for lung cancer.

Related Questions

What are the non molecular mechanisms underlying the association between COPD and lung cancer?4 answersThe association between COPD and lung cancer involves non-molecular mechanisms such as chronic inflammation, oxidative stress, and genetic/epigenetic modifications. COPD patients exhibit a higher risk of developing lung cancer due to factors like genomic instability, immune dysregulation, and alterations in the lung microenvironment. Chronic inflammation accompanying COPD can drive the progression of malignancy, with a notable percentage of COPD cases transitioning to lung cancer annually. Additionally, oxidative stress induced by tobacco smoking contributes to DNA damage, promoting lung carcinogenesis in COPD patients. These non-molecular mechanisms collectively create a conducive environment for the development and progression of lung cancer in individuals with COPD, highlighting the intricate interplay between these two conditions.
What are the most common risk factors for developing lung cancer?5 answersThe most common risk factors for developing lung cancer include smoking, exposure to environmental pollutants like outdoor air pollution and indoor air pollution, occupational factors such as asbestos exposure, family history of lung cancer, and infections. Smoking is a predominant risk factor, but a significant percentage of lung cancer cases occur in non-smokers due to other factors. Additionally, demographic variables like education level, income, age group, and ethnicity play a role in lung cancer incidences. While alcohol and coffee consumption may increase the risk, tea intake has a protective effect against lung cancer. Early diagnosis through various investigations like chest x-ray and CT scans, along with minimizing exposure to carcinogens, is crucial for combating lung cancer.
Is smoking associated with lung cancer?5 answersSmoking is strongly associated with lung cancer. Studies have shown that cigarette smoking is a major risk factor for lung cancer, with up to 90% of lung cancer cases being attributed to smoking. The carcinogens present in cigarette smoke can bind to DNA molecules and cause irreversible mutations in cancer genes, such as TP53 and KRAS. The risk of developing lung cancer is higher in individuals who smoke more cigarettes per day, have a longer duration of smoking, and start smoking at a younger age. Additionally, exposure to environmental tobacco smoke (ETS) in the workplace and at home also increases the risk of lung cancer, particularly in nonsmokers. Overall, smoking is a major etiological factor for lung cancer, and efforts to reduce smoking rates are crucial in preventing this disease.
What are the risk factors of lung cancer?5 answersThe risk factors of lung cancer include smoking, environmental pollution, occupational factors, and demographic variables such as education, income level, age group, and ethnicity. Other risk factors for lung cancer in non-smokers include indoor air pollution, exposure to environmental tobacco smoke, occupational exposure to substances like asbestos and radiation, family history, and infections. Studies have shown that exposure to particulate matter with <2.5 µm diameter (PM2.5) in air pollution is associated with an increased risk of lung cancer. Additionally, factors like consistent alcohol consumption and a history of lung-related diseases have been identified as risk factors for lung cancer. It is important to minimize exposure to these risk factors and implement strategies to prevent and treat lung cancer.
What are the factors associated with lung cancer in Bangladesh?4 answersFactors associated with lung cancer in Bangladesh include higher education level and higher monthly household income, which are associated with shorter intervals between first contact with a healthcare provider and diagnosis, as well as initiation of treatment. Consulting with additional healthcare providers prior to diagnosis is associated with longer intervals in the care seeking pathway. The prevalence of lung cancer is higher in males compared to females, and smoking is identified as the highest risk factor for male patients. Other risk factors for lung cancer in Bangladesh include previous lung disease, highly cooked food, genetic inheritance, and tobacco leaf intake. Socio-economic status and education level also play important roles in causing lung cancer, with a higher percentage of patients living in rural areas and below the poverty line, and having lower levels of education.
Does smoking increase lung cancer risk?0 answersSmoking is a significant risk factor for lung cancer. Studies have shown that individuals who smoke have an increased risk of developing lung cancer compared to non-smokers. The risk of lung cancer is directly related to the number of pack-years smoked, with a higher risk associated with a greater number of pack-years. Additionally, exposure to environmental tobacco smoke (ETS) also increases the risk of lung cancer. Quitting smoking can reduce the risk of developing lung cancer, as the risk decreases with increasing quit age. Therefore, it is clear that smoking significantly increases the risk of lung cancer.

See what other people are reading

What are the potential health risk of phytochemicals?
5 answers
Phytochemicals, while generally considered safe, can pose health risks if consumed in high doses or long-term. Some phytochemicals like pyrrolizidine alkaloids, steroidal glycoalkaloids, and furanocoumarins have been identified as toxic, causing organ damage, carcinogenicity, mutagenicity, and even death. However, certain phytochemicals like curcumin, resveratrol, quercetin, and cannabinoids have shown anticancer effects by modulating signaling pathways, inducing apoptosis, and inhibiting excessive cell proliferation. Additionally, some phytochemicals can be toxic to animals and humans, such as anticholinergic compounds, cardiac glycosides, and cyanogens, but have also been utilized for therapeutic purposes. Despite these risks, bioactive compounds in foods can help modulate metabolic processes and serve as alternative treatments for metabolic disorders, aiding in restoring normal intestinal flora and preventing abnormal metabolic pathways and immune responses.
How many people may have copd in canadians?
5 answers
Based on various studies, the prevalence of Chronic Obstructive Pulmonary Disease (COPD) in Canada is estimated to be significant. Self-reported diagnosis underestimates the actual prevalence, with spirometry data indicating a much higher prevalence. Approximately 4% of Canadians over 35 years old have been diagnosed with COPD, although this is likely an underestimate. A more recent study using data from the Canadian Community Health Survey in 2014 found an overall COPD prevalence of 5.69% among individuals aged 35 and older. These findings suggest that COPD affects a substantial number of Canadians, with estimates ranging from 4% to 5.69% of the population, highlighting the importance of addressing this chronic respiratory condition in Canada.
What are the most recent studies in autophagy?
5 answers
Recent studies in autophagy have highlighted its diverse roles in various physiological and pathological conditions. Autophagy, the process of cellular components being broken down by lysosomes, plays a crucial role in maintaining cell homeostasis. It has been associated with the development of different pathologies, including cancer and neurological disorders, acting as both a cytoprotective and cytotoxic mechanism. Autophagy has been extensively studied in lung diseases, such as pulmonary hypertension, acute lung injury, and lung cancer, revealing its regulatory role in these conditions. Moreover, research on the autophagy of pancreatic cancer has shown a growing interest in topics like metabolic reprogramming, mTOR-mediated apoptosis, and autophagy-dependent ferroptosis, indicating promising future trends in this area. Mass spectrometry-based proteomic methods have also proven valuable in uncovering the range of degradation substrates of autophagy.
Who are relavent stakholders for screening test of breast cancer?
5 answers
Relevant stakeholders for breast cancer screening tests include breast cancer screening experts, primary care providers (PCPs), patients with limited health literacy (LHL), physicians, surgeons, occupational therapists, community leaders, program officers, public health professionals, and breast cancer survivors. These stakeholders play crucial roles in providing input on screening methods, risk assessment, informational needs, barriers, facilitators, and implementation strategies for effective breast cancer screening programs. Breast cancer screening experts, PCPs, and patients with LHL offer diverse perspectives on screening decisions, emphasizing the importance of incorporating multiple stakeholder views in decision aids for mammography screening, especially for younger women with limited health literacy. Collaborative efforts involving these stakeholders are essential for developing comprehensive and inclusive breast cancer screening and treatment initiatives to address the increasing cancer burden and improve patient outcomes.
What is exozome medications treatment?
5 answers
Exosome medications are innovative treatments that utilize exosomes, which are small vesicles released by cells, to deliver therapeutic cargo to target cells. These cargos can include various components such as short interference RNA (siRNA) for gene expression modification, correction of mutations, depletion of specific proteins, or delivery of cancer antigens for immunotherapy. Exosome-based treatments have shown promising results in addressing a range of conditions, including sickle cell disease, Non-Alcoholic Steatohepatitis, Diabetes Mellitus, cardiovascular diseases, and cancer. By harnessing the therapeutic potential of exosomes, these medications offer a novel approach to precision medicine and targeted therapy for various diseases.
Trisomy 21 and Periodontitis in patients who have had cancer treatment?
5 answers
Trisomy 21 patients with periodontitis have shown the presence of herpesviruses and periodontopathic bacteria in their oral microbiome. Additionally, cancer patients with periodontitis exhibit higher levels of IL-6 and T regulatory cells (Treg) in their peripheral blood, potentially contributing to immunosuppression and cancer progression. Furthermore, a study on the systemic impact of periodontitis revealed that proper treatment for periodontitis can reduce cancer risk, indicating that periodontitis is a modifiable risk factor for cancer. Moreover, a large-scale retrospective cohort study demonstrated a significant association between periodontitis and increased cancer risk, including stomach, colon, lung, bladder, thyroid, and leukemia cancers, even after adjusting for confounding factors. Therefore, Trisomy 21 patients who have undergone cancer treatment and have periodontitis may face a complex interplay of factors affecting their oral health and cancer risk.
Periodontitis in patients who have had cancer treatment?
4 answers
Periodontitis in patients who have undergone cancer treatment can have significant implications. Research suggests that periodontitis may impact cancer occurrence and progression. Patients with both periodontitis and cancer show increased levels of T regulatory cells (Treg) and IL-6 in peripheral blood, potentially contributing to immunosuppression and cancer progression. Moreover, individuals with periodontitis have a higher overall cancer risk, including specific cancers like prostate, thyroid, stomach, colon, lung, bladder, thyroid, and leukemia. Proper treatment for periodontitis has been shown to reduce cancer risk, indicating that periodontitis is a modifiable risk factor for cancer. Dental care for cancer patients is crucial, as chemotherapy can exacerbate oral health issues, emphasizing the need for specialized dental treatment in this population.
What are the potential long-term effects of chronic emotional stress on tissue health?
5 answers
Chronic emotional stress can have profound long-term effects on tissue health. Prolonged exposure to stress can lead to maladaptation, resulting in altered neuroendocrine parameters and potential illness development. Chronic stress can exhaust the body's capacity for an adequate reaction, leading to immunological dysfunction and impairing overall health and quality of life. In the context of colon cancer, chronic stress has been associated with detrimental effects on tissue health, impacting colon inflammation and ornithine decarboxylase (ODC) expression, which plays a role in hyperproliferative diseases. These findings highlight the intricate relationship between chronic emotional stress and tissue health, emphasizing the importance of managing stress to prevent long-term negative consequences on overall well-being.
How much cell death occur in lung cancer 3D models after transfection with ANT1 pDNA?
5 answers
Transfection of ANT1 pDNA induces significant cell death in lung cancer 3D models. ANT1 over-expression triggers apoptosis in cancer cells, leading to reduced tumor growth in vivo. Additionally, the use of reversed caspase-3 expression vectors has shown to increase apoptosis in lung adenocarcinoma cells, indicating a strong effect on cell death. Moreover, the application of tumor-on-chip technology has allowed for the observation of cytotoxic effects on human lung cancer cells, highlighting the impact of cancer cell death induced by various stimuli, including chemotherapy drugs and immune cells. These findings collectively suggest that ANT1 transfection can effectively promote cell death in lung cancer models, emphasizing its potential as a therapeutic strategy for cancer treatment.
What morpholological changes does nigericin cause in cells?
5 answers
Nigericin induces significant morphological changes in cells by disrupting mitochondrial membrane potential, triggering cytochrome c release, and activating caspase-9-mediated apoptosis. Additionally, nigericin causes ribosome stalling by depleting cytosolic potassium ions, leading to ribotoxic stress response activation and subsequent pyroptosis in human keratinocytes. These morphological alterations are accompanied by a decrease in tumor cell proliferation, suppression of Wnt/β-catenin signaling pathway, and induction of apoptosis in colorectal cancer cells. The diverse effects of nigericin on cellular morphology highlight its potential as a therapeutic agent for various conditions, including primary effusion lymphoma, inflammasome activation, and colorectal cancer.
What is the permanence time of phytochemicals in the gastrointestinal tract?
4 answers
The permanence time of phytochemicals in the gastrointestinal tract varies based on their properties. Phytochemicals have low bioavailability and extended retention in the intestine due to poor absorption, impacting the gut microbiota positively. Predicting the time to achieve maximal plasma concentration (Tmax) of phytochemicals is crucial for optimizing their bio-efficacy in managing oxidative stress and inflammation in chronic diseases. Factors like lipophilicity, molecular mass, and polar surface area influence the Tmax of phytochemicals, reflecting their absorption properties. Understanding the physicochemical properties of phytochemicals aids in predicting their gastrointestinal absorption after oral administration, potentially enhancing their bioavailability and therapeutic effects. Overall, the permanence time of phytochemicals in the gastrointestinal tract is influenced by their structural characteristics and absorption mechanisms, impacting their health benefits.